Clinical Trial Update: An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer [Phase 2]

View source ↗

Summary

This document reports the completion results of an open Phase 2 trial evaluating the efficacy and safety of oral thalidomide in patients with hormone-refractory…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Hormone-refractory Prostate Cancer | Phase 2 | Status: COMPLETED